Zobrazeno 1 - 10
of 630
pro vyhledávání: '"Schoedel KA"'
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2014, Iss default, Pp 1161-1174 (2014)
Kerri A Schoedel,1 Sarah A Morrow,2 Edward M Sellers3,4 1Altreos Research Partners, Inc., Toronto, 2Western University, London, 3DL Global Partners, Inc., Toronto, 4University of Toronto, Toronto, Ontario, Canada Abstract: Pseudobulbar affect (PBA) i
Externí odkaz:
https://doaj.org/article/930cbf7bce314eed9687b3801c1446fe
Autor:
Schoedel KA; Altreos Research Partners, Inc, Toronto, Canada. kschoedel@altreos.com., Kolly C; Novartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Gardin A; Novartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Neelakantham S; Novartis Institutes for Biomedical Research, Novartis Healthcare Pvt Ltd, Hyderabad, India., Shakeri-Nejad K; Novartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, Switzerland.
Publikováno v:
Psychopharmacology [Psychopharmacology (Berl)] 2022 Jan; Vol. 239 (1), pp. 1-13. Date of Electronic Publication: 2021 Nov 13.
Autor:
Shram MJ, Levy-Cooperman N; From the Altreos Research Partners, Inc., Ratcliffe S; Department of Pharmacology and Toxicology, University of Toronto., Mills C; INC Research, Toronto, Ontario, Canada., Bartlett C; INC Research, Toronto, Ontario, Canada., Chen N; INC Research, Toronto, Ontario, Canada., Setnik B; Pfizer Inc., Durham, NC., Sellers EM, Schoedel KA; From the Altreos Research Partners, Inc.
Publikováno v:
Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2020 Nov/Dec; Vol. 40 (6), pp. 568-578.
Autor:
Ufer M; Idorsia Pharmaceuticals Ltd, Department of Clinical Pharmacology, Allschwil, Switzerland., Kelsh D; Phase 1 Clinical Development, Altasciences Clinical Kansas, Inc., Overland Park, KS, USA., Schoedel KA; Altreos, Research Partners, Inc., Toronto, ON, Canada., Dingemanse J; Idorsia Pharmaceuticals Ltd, Department of Clinical Pharmacology, Allschwil, Switzerland.
Publikováno v:
Sleep [Sleep] 2022 Mar 14; Vol. 45 (3).
Autor:
Birnbaum, Angela (AUTHOR)
Publikováno v:
Epilepsy Currents. Nov/Dec2019, Vol. 19 Issue 6, p382-384. 3p.
Autor:
Mick, Gérard1,2,3,4 (AUTHOR) GMick@chu-grenoble.fr, Douek, Pascal5 (AUTHOR)
Publikováno v:
Pain & Therapy. Oct2024, Vol. 13 Issue 5, p1063-1094. 32p.
Autor:
Schoedel KA; Altreos Research Partners, Inc., Toronto, Canada., Gillespie M; Teva Pharmaceuticals, Inc., Malvern, PA, USA., Levy-Cooperman N; Altreos Research Partners, Inc., Toronto, Canada., Shram MJ; Altreos Research Partners, Inc., Toronto, Canada., Rabinovich-Guilatt L; Teva Pharmaceuticals, Inc., Malvern, PA, USA.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2019 Jan; Vol. 8 (1), pp. 32-39. Date of Electronic Publication: 2018 May 03.
Autor:
Göhler K, Sokolowska M; Medical Affairs and Center for Abuse Prevention and Evaluation, Grünenthal USA, Morristown, NJ., Schoedel KA; INC Research Early Phase, Toronto, Ontario, Canada (currently Altreos Research Partners, Inc)., Nemeth R; Data Sciences-Biostatistics, and., Kleideiter E, Szeto I; INC Research Early Phase, Toronto, Ontario, Canada (currently Altreos Research Partners, Inc)., Eerdekens MH; Clinical Science Pain, Grünenthal GmbH, Aachen, Germany.
Publikováno v:
Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2019 Jan/Feb; Vol. 39 (1), pp. 46-56.
Autor:
Schoedel KA; Altreos Research Partners Inc., 50 Wanda Road, Toronto, ON, M6P1C6, Canada. Electronic address: kschoedel@altreos.com., Szeto I; Syneos Health, 3201 Beechleaf Court, Suite 600, Raleigh, NC 27604-1547, USA(1)., Setnik B; Syneos Health, 3201 Beechleaf Court, Suite 600, Raleigh, NC 27604-1547, USA(1); University of Toronto, Department of Pharmacology and Toxicology, Medical Sciences Building, Room 4207, 1 King's College Circle, Toronto, Ontario M5S 1A8, Canada. Electronic address: beatrice.setnik@syneoshealth.com., Sellers EM; University of Toronto, Department of Pharmacology and Toxicology, Medical Sciences Building, Room 4207, 1 King's College Circle, Toronto, Ontario M5S 1A8, Canada., Levy-Cooperman N; Altreos Research Partners Inc., 50 Wanda Road, Toronto, ON, M6P1C6, Canada. Electronic address: Nlevy-cooperman@altreos.com., Mills C; Syneos Health, 720 King Street West, 7th Floor, Toronto, ON M5V 2T3, Canada. Electronic address: catherine.mills@syneoshealth.com., Etges T; GW Research Ltd., Cambridge, UK. Electronic address: tge@gwpharm.com., Sommerville K; Greenwich Biosciences, Inc., Carlsbad, CA, USA. Electronic address: KSommerville@greenwichbiosciences.com.
Publikováno v:
Epilepsy & behavior : E&B [Epilepsy Behav] 2018 Nov; Vol. 88, pp. 162-171. Date of Electronic Publication: 2018 Oct 02.
Autor:
Bond M; Teva Pharmaceuticals, Inc., Malvern, Pennsylvania, USA., Schoedel KA; Altreos Research Partners, Inc., Toronto, ON, Canada., Rabinovich-Guilatt L; Teva Pharmaceuticals, Inc., Malvern, Pennsylvania, USA., Gasior M; Teva Pharmaceuticals, Inc., Frazer, Pennsylvania, USA., Tracewell W; Teva Pharmaceuticals, Inc., West Chester, Pennsylvania, USA., Malamut R; RM is a former employee of Teva Pharmaceuticals, Inc., Ma Y; Teva Pharmaceuticals, Inc., Frazer, Pennsylvania, USA., Webster LR; PRA Health Sciences, Salt Lake City, Utah, USA.
Publikováno v:
Pain medicine (Malden, Mass.) [Pain Med] 2018 Aug 01; Vol. 19 (8), pp. 1597-1612.